The purpose of this reissuance is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM.
The proposed project
must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs:
Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs.
Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.